Trial Profile
A phase I/II study of VB-210 for the treatment of Muscle Spasticity in patients with Multiple Sclerosis
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs VB 210 (Primary)
- Indications Muscle spasticity
- Focus Adverse reactions; Therapeutic Use
- 04 Aug 2016 New trial record